Free Trial Information
BioCentury | Oct 5, 2015
Clinical News

StreptAnova: Phase I started

...exclusive, worldwide rights from Vaxent to develop and commercialize StreptAnova. Vaxent LLC , Memphis, Tenn. Pan-Provincial Vaccine Enterprise Inc. (PREVENT)...
Read More
BioCentury | Aug 19, 2013
Company News

Amorfix, Pan-Provincial Vaccine Enterprise Inc. (PREVENT) deal

...of preclinical testing (see BioCentury, June 14, 2012). Amorfix Life Sciences Ltd. (TSX:AMF), Mississauga, Ontario Pan-Provincial Vaccine Enterprise Inc. (PREVENT)...
Read More
BioCentury | Mar 19, 2012
Company News

Amorfix deal

Amorfix exercised its 2005 option to acquire the superoxide dismutase 1 (SOD1) technology it had licensed from Amorfix's CSO Neil Cashman. Cashman will receive 444,444 units, with each unit comprising a share of Amorfix and...
Read More
BioCentury | Jun 14, 2010
Company News

Amorfix, Pan-Provincial Vaccine Enterprise Inc. deal

...a commercial partner. Further terms were not disclosed. Amorfix Life Sciences Ltd. (TSX:AMF), Mississauga, Ontario Pan-Provincial Vaccine Enterprise Inc. (PREVENT)...
Read More
Items per page:
1 - 4 of 4
BioCentury | Oct 5, 2015
Clinical News

StreptAnova: Phase I started

...exclusive, worldwide rights from Vaxent to develop and commercialize StreptAnova. Vaxent LLC , Memphis, Tenn. Pan-Provincial Vaccine Enterprise Inc. (PREVENT)...
Read More
BioCentury | Aug 19, 2013
Company News

Amorfix, Pan-Provincial Vaccine Enterprise Inc. (PREVENT) deal

...of preclinical testing (see BioCentury, June 14, 2012). Amorfix Life Sciences Ltd. (TSX:AMF), Mississauga, Ontario Pan-Provincial Vaccine Enterprise Inc. (PREVENT)...
Read More
BioCentury | Mar 19, 2012
Company News

Amorfix deal

Amorfix exercised its 2005 option to acquire the superoxide dismutase 1 (SOD1) technology it had licensed from Amorfix's CSO Neil Cashman. Cashman will receive 444,444 units, with each unit comprising a share of Amorfix and...
Read More
BioCentury | Jun 14, 2010
Company News

Amorfix, Pan-Provincial Vaccine Enterprise Inc. deal

...a commercial partner. Further terms were not disclosed. Amorfix Life Sciences Ltd. (TSX:AMF), Mississauga, Ontario Pan-Provincial Vaccine Enterprise Inc. (PREVENT)...
Read More
Items per page:
1 - 4 of 4